| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |